Generic placeholder image

Current Protein & Peptide Science

Editor-in-Chief

ISSN (Print): 1389-2037
ISSN (Online): 1875-5550

Editorial

Bcl-2 Family Proteins in Therapeutic Arena for Cancers

Author(s): T. Sivaraman

Volume 24, Issue 10, 2023

Published on: 20 October, 2023

Page: [781 - 782] Pages: 2

DOI: 10.2174/138920372410231020092906

Next »
[1]
Nitin, S.; Anil, K.S. Caspase-3 activators as anticancer agents. Curr. Protein Pept. Sci., 2023, 24(10), 783-804.
[2]
Amit, G.; Prashant, R.S.; Ashish, P.S.; Neha, K.; Jyoti, J.; Niharika, S.; Sonal, M.; Jainendra, P.; Rajeshwar, P.S. Anticancer compounds from cyanobacteria and their implications in apoptosis. Curr. Protein Pept. Sci., 2023, 24(10), 805-819.
[3]
Jhimli, B.; Sovan, S.; Rubai, A.; Sandeep, K.D. Bioactive pentacyclic triterpenes trigger multiple signalling pathways for selective apoptosis leading to anticancer efficacy: Recent Updates and future perspectives. Curr. Protein Pept. Sci., 2023, 24(10), 820-842.
[4]
Gunasekaran, V.P.; Sivaraman, T.; Ganeshan, M. Apoptotic switch in cancer stem cells: A potential approach for cancer treatment. Curr. Protein Pept. Sci., 2023, 24(10), 843-852.
[5]
Sundra, D.S.; Arumugam, M.; Kandasamy, K.; Kumpati, P. BH3 mimetic peptides: An effective strategy to complement anticancer therapy. Curr. Protein Pept. Sci., 2023, 24(10), 853-864.

© 2024 Bentham Science Publishers | Privacy Policy